CRISPR Therapeutics AG vs. Allogene Therapeutics, Inc. – Trademark Opposition TTAB Proceeding 91247245

This Opposition was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on March 27, 2019 and assigned serial number 91247245 by the TTAB.

Defendant:
Allogene Therapeutics, Inc. represented by JASON S HOWELL of PERKINS COIE LLP.
Trademark Information: ALLOCAR T – US Trademark Serial Number 88117993
View Trademark Status at USPTO
View Trademark Documents at USPTO

Plaintiff:
CRISPR Therapeutics AG represented by TIFFANY D GEHRKE of MARSHALL GERSTEIN & BORUN LLP.

Prosecution History:
March 27, 2019 – FILED AND FEE
March 27, 2019 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
March 27, 2019 – PENDING, INSTITUTED
May 06, 2019 – D MOT TO DISMISS: FRCP 12(B)
May 07, 2019 – D CHANGE OF CORRESP ADDRESS
May 28, 2019 – P MOT TO AMEND PLEADING/AMENDED PLEADING
May 30, 2019 – RESPONSE DUE 30 DAYS (DUE DATE)
May 30, 2019 – RESPONSE DUE 30 DAYS (DUE DATE)
June 10, 2019 – TRIAL DATES RESET
June 10, 2019 – ANSWER
June 10, 2019 – D MOT TO CONSOLIDATE
July 01, 2019 – P OPP/RESP TO MOTION
July 11, 2019 – SUSPENDED
July 22, 2019 – D REPLY IN SUPPORT OF MOTION
October 31, 2019 – CONSOLIDATED W/91247247; DATES RESET
November 26, 2019 – D CHANGE OF CORRESP ADDRESS
December 13, 2019 – P MOT FOR EXT W/ CONSENT
December 13, 2019 – EXTENSION OF TIME GRANTED
February 14, 2020 – P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
February 14, 2020 – SUSPENDED
March 13, 2020 – P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
March 13, 2020 – SUSPENDED
April 13, 2020 – P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
April 13, 2020 – SUSPENDED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *